✦ LIBER ✦

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphatic leukemia

✍ Scribed by P. R.

Book ID: 112944179
Publisher: Springer US
Year: 1985
Tongue: English
Weight: 118 KB
Volume: 2
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02934784

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between plasma adriamycin l

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

✍ Harvey D. Preisler; Teresa Gessner; Nozar Azarnia; Wanda Bolanowska; Joshua Epst 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 456 KB

Relationship between patients' age, bone

Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia

✍ Dr. Ph. Bernard; F. Lacombe; J. Reiffers; B. David; G. Marit; M. J. Bourdeau; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Bone marrow karyotypes were performed in 88 cases of adult acute myelogenous leukemia (AML) at diagnosis and classified NN (normal), AA (abnormal), and AN (mixture of normal and abnormal metaphases). A clear relationship was found between karyotype and complete remission (CR) rate: 58% CR in (NN + A

Relationship between the per cent of mar

Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia

✍ H. D. Preisler; N. Azarnia; A. Raza; H. Grunwald; R. Vogler; G. Browman; J. Gold 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Changes in the characteristics of the bo

Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapy

✍ Preisler, Harvey D; Raza, Azra; Azarnia, Nozar; Rakowsky, Irene; Barcos, Maurice 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 875 KB

Adverse effects of aneuploidy on the out

Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure

✍ H. D. Preisler; Peter A. Reese; SMichelle J. Marinello; Lillian Pothier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB

Relation between the duration of remissi

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen

✍ Mary Ann Weiser; Maria E. Cabanillas; Marina Konopleva; Deborah A. Thomas; Sherr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Abstract ## BACKGROUND Hyperglycemia, which is not uncommon during the treatment of acute lymphocytic leukemia (ALL), has been shown to be an independent predictor of adverse outcomes among hospitalized patients with undiagnosed diabetes; it also may have the potential to affect leukemic cell p